23/07/2025 - SYRES is CIR and CII accredited: what this means for you

Good news for our current and future partners: SYRES is officially approved for the Research Tax Credit (CIR) and the Innovation Tax Credit (CII) until 2027.

But concretely, what does this mean for you ?

🔍 CIR and CII: a helping hand for your R&D projects

When you collaborate with Syres on studies involving a research or innovation dimension (development of new protocols, exploration of mechanisms of action, advanced consumer tests, etc.), part of the expenses incurred may be eligible for a tax credit.

It is a powerful lever for:

• Support your innovation efforts,

• Reduce your R&D investments,

• Optimize your product development budgets.

💡 What are the concrete benefits?

• 30% tax credit on eligible research expenditure, up to 100 million euros per year,

• 5% beyond,

• And for projects falling within the framework of the Innovation Tax Credit (ITC), additional support for the development of innovative products.

🧪 Concrete examples?

• Consumer studies aimed at validating the effectiveness or acceptability of a new formula,

• Development of new protocols to measure well-being or emotions,

• Advanced processing and analysis of data from panels,

• Integration of new technologies (AI, analytical tools, etc.) into investigation processes.

🤝 Why choose SYRES?

Because we combine:

• There’s nothing quite like a recognized expertise in sensory testing, qualitative and quantitative studies,

• There’s nothing quite like a innovation capacity constant, particularly in digital tools and tailor-made protocols,

• There’s nothing quite like a collaborative approach with your R&D, marketing or regulatory teams.

📩 Let's talk about it!

Do you have a development, consumer study or claim validation project?
We help you to maximize value… and optimize your budgets.

Contact our team to discuss the possibilities offered by the CIR/CII in the context of your future projects!